pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 29·1 min read
save

US says Ebola patients will be evacuated to Europe, not treated in America, as outbreak grows

May 29, 2026·read at STAT ↗RegulatoryNegative

The World Health Organization is reviewing which vaccines could help curb the expanding Ebola outbreak in Africa.

The U.S. government announced it will no longer bring Americans infected with Ebola to U.S. treatment facilities.

Instead, patients will be evacuated to unspecified locations in Europe, a move the administration says will speed care.

Health experts criticized the decision as a further retreat from global health leadership amid the third-largest Ebola outbreak on record.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Which vaccines will curb the Ebola outbreak? WHO debates”

read at STAT ↗
1,120 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GILEAD2Mapp Biopharmaceutical Inc
drugs
Ebola Zaire vaccineMOUNJARONVCov-2ROzempicRybelsusVEKLURYWegovyWegovy PillZEPBOUNDremdesivirsemaglutidetirzepatide
topics
Vaccines7GLP-1 receptor2Obesity2Psychiatry & CNS2ImmunologyVaccine

related stories

  • Aug 5Novo CEO sees innovation as a matter of survival amid pipeline setbacksBioSpace
  • Jul 23Chutes & Ladders—Biogen R&D vet gets in FormationFierce Biotech
  • Jul 9Opinion: Who benefits from classifying obesity as a disease?STAT
  • Jul 7Ebola outbreak exposes a fractured outbreak response systemSTAT
  • Jun 3STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and moreSTAT